Ospedale Regionale di Locarno Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2004
NCT00600639
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Ospedale Regionale di Locarno | Ospedale Regionale Locarno

Active Ingredients

Drugs in Phase 4 Trials (3)

albuterol (proventil) (1 trial)

prednisone (meticorten) (1 trial)

sodium bicarbonate (1 trial)

Drugs in Other Trials (1)

darbepoetin alfa (aranesp) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Respiratory Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4